New data shows significantly improved clinical outcomes and lower drug spending for patients with complex, high-cost conditions enrolled in our SafeGuardRxSM programs.
This first-to-market value-based program improves patient engagement and increases medication adherence while reducing costs for some of the costliest therapies.
The Express Scripts Diabetes Care Value program reduced diabetes drug spending by 19% and reduced heart attack risk in 15% of patients.
Innovative treatments, new technologies and greater connectivity bring promise to the health care landscape.
Express Scripts is working to control costs with high-touch clinical care for the more than 30 million people in the U.S. living with diabetes.